QuidelOrtho (QDEL) EBITDA Margin (2021 - 2024)

QuidelOrtho has disclosed EBITDA Margin across 4 years of filings, most recently posting 239.41% for Q1 2024.

• EBITDA Margin for Q1 2024 came in at 239.41%, down 25118.0% year-over-year; the trailing twelve-month figure through Mar 2024 was 58.38% (down 7413.0% YoY), and the FY2024 annual result was 73.96%, down 7488.0% from the prior year.
• EBITDA Margin came in at 239.41% for Q1 2024 at QuidelOrtho, down from 6.67% in the prior quarter.
• In the past five years, EBITDA Margin ranged from a high of 61.93% in Q2 2022 to a low of 239.41% in Q1 2024.
• The 4-year median for EBITDA Margin is 11.58% (2022), against an average of 5.98%.
• Across the five-year window, EBITDA Margin plunged 181 bps in 2022 and tumbled 25118 bps in 2024, its largest moves.
• QuidelOrtho's EBITDA Margin stood at 55.28% in 2021, then tumbled by 87 bps to 7.25% in 2022, then plunged by 192 bps to 6.67% in 2023, then sank by 3491 bps to 239.41% in 2024.
• The last three EBITDA Margin figures came in at 239.41% (Q1 2024), 6.67% (Q4 2023), and 1.53% (Q3 2023), per Business Quant data.